What is LDOS's health score?

Leidos Holdings, Inc. (LDOS) has a TradeApes health score of 63 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LDOS's estimated fair value?

Based on our 5-year discounted cash flow model, Leidos Holdings, Inc.'s estimated fair value is $76.23 per share, representing a -38.7% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LDOS undervalued or overvalued?

Our model currently rates LDOS as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LDOS... Refresh in a moment for the full analysis.

Leidos Holdings, Inc. (LDOS)

Technology Overvalued low healthy

$124.43

Updated: 2026-06-06

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

55 Mixed

Relative Value

83 Strong

Capital Allocation

45 Mixed

Risk

70 Healthy

Est. Fair Value $76.23

DCF Upside -38.7%

Sector Rank #780 of 7871

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Debt increasing — total debt up more than 10% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.